Skip to main content
Premium Trial:

Request an Annual Quote

NCI to Support Cancer Disparity Centers

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Cancer Institute plans to spend up to $5.25 million in 2010 to develop, continue, and expand partnerships between institutions in communities that have cancer health disparities, including genomics and proteomics studies and training for researchers involved in these fields.

The grants will give a total of up to $2 million per year for partnerships between NCI-designated Cancer Centers, or groups of centers, and institutions in communities that are underserved for cancer health along racial, ethnic, or socio-economic lines.

The program, formerly known as the Minority Institution/Cancer Center Partnership program, is aimed at fostering and supporting intensive collaborations that seek to develop stronger national cancer programs and to understand significant cancer disparities and the impact of racial and ethnic minority status and socio-economics on cancer treatment and diagnosis.

The applications must address three areas, including cancer research, cancer training, and cancer outreach.

The research aspect of the partnerships could involve collaborations in genomics, proteomics, imaging, nanotechnology, and other cancer-related technologies, said NCI, while the cancer training programs could involve training in translational research in areas such as genomics, proteomics, imaging, nanotechnology, and other related areas.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.